Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma

被引：0
|
作者：
Ray, Arghya
Das, Deepika S.
Song, Yan
Chauhan, Dharminder
Anderson, Kenneth C.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1792
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Identification of Novel Therapeutic Targets in the Clinically Predictive Vk*MYC Mouse Model of Multiple Myeloma
    Chesi, Marta
    Garbitt, Victoria
    Bergsagel, P. Leif
    BLOOD, 2014, 124 (21)
  • [42] Identification of Novel Notch1-Regulated Therapeutic Targets in Multiple Myeloma through Functional shRNA-Based Screening
    Maichl, Daniela Simone
    Ziouti, Fani
    Kirner, Julius Arthur
    Schmidt, Stefanie
    Ade, Carsten Patrick
    Dietrich, Sascha
    Heckel, Tobias
    Jundt, Franziska
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 42 - 42
  • [43] Pescadillo and CYP1B1: Novel metabolic targets in glioma
    Brooks, S.
    Daley, F.
    Johns, P.
    Brandner, S.
    Short, S. C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S72 - S73
  • [44] Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes
    Bjorkman, Mari
    Rantala, Juha
    Nees, Matthias
    Kallioniemi, Olli
    EPIGENOMICS, 2010, 2 (05) : 683 - 689
  • [45] Identification of conserved and novel mature miRNAs in selected crops as future targets for metabolic engineering
    Noor, Fatima
    Alshamrani, Rahma
    Gull, Munazza
    Mehmood, Muhammad Aamer
    Aslam, Sidra
    ASIAN JOURNAL OF AGRICULTURE AND BIOLOGY, 2021, 9 (02): : 1 - 12
  • [46] Identification of Novel Targets Based on Splicing Alterations for Undruggable RAS/CDK Signaling Cascade in Multiple Myeloma
    Adamia, Sophia
    Chyra, Zuzana
    O'Keefe, Morgan
    Bhatt, Shruti
    Wen, Kenneth
    Fell, Geoffrey G.
    Tai, Yu-Tzu
    Letai, Anthony G.
    Abiatari, Ivane
    Dorfman, David M.
    Hideshima, Teru
    Anderson, Kenneth C.
    BLOOD, 2021, 138
  • [47] Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets
    Mienda, Bashir Sajo
    Salihu, Rabiu
    Adamu, Aliyu
    Idris, Shehu
    FUTURE MICROBIOLOGY, 2018, 13 (04) : 455 - 467
  • [48] Metabolic Diseases Downregulate the Majority of Histone Modification Enzymes, Making a Few Upregulated Enzymes Novel Therapeutic Targets—“Sand Out and Gold Stays”
    Ying Shao
    Valeria Chernaya
    Candice Johnson
    William Y. Yang
    Ramon Cueto
    Xiaojin Sha
    Yi Zhang
    Xuebin Qin
    Jianxin Sun
    Eric T. Choi
    Hong Wang
    Xiao-feng Yang
    Journal of Cardiovascular Translational Research, 2016, 9 : 49 - 66
  • [49] NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
    Fionda, Cinzia
    Soriani, Alessandra
    Zingoni, Alessandra
    Santoni, Angela
    Cippitelli, Marco
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [50] Identification of novel targets for multiple myeloma through integrative approach with Monte Carlo cross-validation analysis
    Liu, Congjian
    Gu, Xiang
    Jiang, Zhenxian
    JOURNAL OF BONE ONCOLOGY, 2017, 8 : 8 - 12
12345